NOVAVAX INC
NVAXNASDAQ🏆 #1954 by market capEarnings Nov 5US Equity
$7.95▲ $0.06 (+0.76%)
Market closed · at close1h—
24h▲ 0.8%
7d—
14d—
30d—
1y—
🏦Market Cap
$1.31B
Small Cap
📈Revenue Growth (YoY)
+64.7%
High Growth
📊Gross Margin
77.8%
High
💵FCF Margin
-10.5%
Thin
⚖️P/S Ratio
3.2x
Fair
Otter Score
60
Fair
📊
Analyst Ratings
Price
$7.95
Total
23
Raised
2
Lowered
5
Avg PT
$18.00
H / L
$25 / $11
| Institution | Action | Rating | Date |
|---|---|---|---|
BTIG | Reiterated | Buy | 2026-06-11 |
TD Cowen | Reiterated | Hold | 2026-05-06 |
HC Wainwright & Co. | Reiterated | Buy | 2026-02-27 |
JP Morgan | Reiterated | Underweight | 2025-11-18 |
B. Riley Securities | Reiterated | Buy | 2025-11-10 |
B of A Securities | Downgraded | Neutral → Underperform | 2025-08-20 |
Cowen & Co. | Reiterated | Outperform | 2022-08-09 |
Cantor Fitzgerald | Reiterated | Overweight | 2022-06-08 |
B. Riley FBR | Reiterated | Buy | 2021-02-18 |
Jefferies | Reiterated | Buy | 2020-12-14 |
Citigroup | Upgraded | Neutral → Buy | 2020-11-25 |
PiperJaffray | Downgraded | Overweight → Neutral | 2020-11-25 |
Ladenburg Thalmann | Downgraded | Buy → Neutral | 2020-11-25 |
Seaport Global | Upgraded | Neutral → Buy | 2020-11-25 |
McNicoll Lewis Vlak | Reiterated | Buy | 2020-11-25 |
Citi | Reiterated | Buy | 2020-11-25 |
Wedbush | Downgraded | Buy → Neutral | 2020-11-25 |
Oppenheimer | Reiterated | Outperform | 2020-11-25 |
Lazard | Reiterated | Buy | 2020-11-25 |
Chardan Capital | Reiterated | Neutral | 2020-11-25 |
H.C. Wainwright | Reiterated | Buy | 2020-05-12 |
Piper Sandler | Downgraded | Overweight → Underweight | 2019-02-28 |
B. Riley | Reiterated | Buy | 2018-01-10 |
One row per institution, most recent rating